AVX-002

N/A

Report date: 2025/01/26 17:06:37
NME

Base Information

Drug NameAVX-002
Drug Alias NameAVX-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytosolic phospholipase A2 inhibitors
TargetsCytosolic phospholipase A2
Therapy Area/IndicationsGlomerulonephritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoegin Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesCoegin Pharma AB
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A